Hatteras Venture Partners
Venture capitalResearch Triangle · Seed–Series C · 27 people tracked
Also known as HATTERAS VENTURE ADVISORS III, LLC · HATTERAS VENTURE ADVISORS IV, LLC · HATTERAS VENTURE ADVISORS V LLC · HATTERAS VENTURE ADVISORS VI, LLC · HATTERAS VENTURE ADVISORS VII, LLC
Find your way into Hatteras Venture Partners
997 people in our graph share verified history with the Hatteras Venture Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Hatteras Venture Partners invests in high-quality science and teams pursuing breakthrough ideas with significant potential impact for patients. The firm prioritizes therapeutic and diagnostic advances as well as companies disrupting the healthcare status quo. Beyond providing capital, it supports portfolio companies with team recruitment, portfolio strategy, business development, and regulatory and clinical planning, aiming to build transformational companies that reach value inflection quickly and efficiently. Based in North Carolina's Research Triangle, the firm is a leader in the Southeast while maintaining a broad North American investment footprint, drawing on over 25 years of experience across more than 100 companies.
Source: firm website, verified Sep 15, 2026.
Team · 27 people
from the firm's website & curated & public directories
Founder mafia
4 people who came through Hatteras Venture Partners went on to found or lead other companies.
What they invest in
from 87 of 145 portfolio companiesHealthtech ×59Biotech ×49Medical Devices ×33Digital Health ×23AI & Machine Learning ×13Deep Tech ×10SaaS ×10Consumer ×6
HQs:United States×81United Kingdom×1
Who they back
founder profiles across 27 portfolio companiesFounding team size:solo founder×142 founders×73 founders×6
Where their founders studiedfrom 22 founders with education data
Duke University ×2University of Minnesota ×2University of Southern California ×2
What their founders studiedfrom 23 founders with field-of-study data
Life Sciences ×5Computer Science ×4Engineering ×4Finance & Accounting ×3Medicine ×3Business & Management ×2Chemistry ×2Economics ×2
Where their founders worked beforefrom 23 founders with career history
The Scripps Research Institute ×3Harvard Medical School ×2Massachusetts General Hospital ×2NuXcel, Ltd ×2
11 founders hold a PhD · 3 hold an MBA (of 25 with degree data)
Investments · 145 tracked
founders shown can be your intro pathBy year:2026 · 52025 · 52024 · 52023 · 42022 · 82021 · 72020 · 62018 · 22017 · 32016 · 22015 · 62014 · 265 dated
Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders.
BiotechHealthtechMedical Devices
Richard F. Pops(Chief Executive Officer and Chairman of the Board)Joshua Reed(Senior Vice President, Chief Financial Officer)inBlair C. Jackson(Executive Vice President, Chief Operating Officer and Chief Risk Officer)inDavid J. Gaffin(Executive Vice President, Chief Legal Officer and Chief Compliance Officer; Secretary)inCraig C. Hopkinson(Executive Vice President, Research and Development and Chief Medical Officer)C. Todd Nichols(Senior Vice President, Chief Commercial Officer)in
Co-investorsBain Capital Life SciencesCardinal PartnersVedanta Capital
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.
BiotechHealthtechMenlo Park, US
Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Sanjay Chanda(Chief Development Officer)inLucy O. Day(Chief Financial Officer)in
Co-investorsAdjuvant CapitalBioRock VenturesFlucas VenturesMountain Group CapitalRA CapitalBiotechnology Value Fund
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in
Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersYsios CapitalAction Potential Venture Capital Ltd.Vensana Capital
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
Nello Mainolfi(Founder)inBruce Booth(Chair)in
Co-investorsAtlas VentureAvoro Capital AdvisorsBain Capital Life SciencesBessemer Venture PartnersMRL Ventures FundNextech Invest+6 more
Shattuck Labs is a biotechnology company developing biologic medicines targeting TNF receptors, including the TL1A/DR3 axis, for patients with cancer and inflammatory or life-altering diseases.
BiotechHealthtechAustin, US
Josiah Hornblower(President/CEO)inTaylor(Co-founder & Chief Executive Officer, Board Member)
BoardWalter Loewenbaum(Director)
Co-investorsEcoR1 CapitalOrbiMedREDMILET. Rowe Price
A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types.
BiotechDigital HealthMedical DevicesDurham, US
Charles M. Perou(Founder and Director)inMICHAEL MILBURN(Executive Officer, Director)inDavid Neil Hayes(Executive Officer, Director)
BoardArnold Levine(Director)
Board seatMyla Lai-GoldmanClay Thorp· per SEC Form D
Co-investorsIAG Capital Partners
Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.
BiotechHealthtechMedical DevicesRaleigh, US
Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)John Fahy(Director)in
BoardChristy Shaffer(Director)inRishi Gupta(Director)inTim Shannon(Director)in
Co-investorsOrbiMedCanaan PartnersPappas Capital
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.
BiotechDeep TechHealthtechMedical DevicesRoseville, US
Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)
BoardTheresa C. Pappas(Director)Ketan Patel(Director)in
Co-investorsTreo Ventures, LlcF-Prime Capital
Boomerang Medical develops a bioelectric neuromodulation device to treat bowel urgency symptoms in patients with ulcerative colitis and other inflammatory bowel disease.
BiotechDigital HealthMedical DevicesMountain View, US
Co-investorsArboretum Ventures
Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.
HardwareHealthtechMedical DevicesRaleigh, US
Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)
Co-investorsLightstone VenturesAmzak HealthMountain Group CapitalUS Venture Partners
Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.
BiotechDigital HealthChapel Hill, US
Jenny Ting(Director and Co-founder)Anil Goyal(CEO and Director)
Co-investorsDelin VenturesOsage University Partners
iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.
BiotechHealthtechMedical DevicesMinneapolis, US
Mudit K. Jain(Co-Founder and Chairman of the Board)Lynn Elliott(Co-Founder and Director)inSteve Masson(President & CEO)in
Co-investorsTreo Ventures, LlcF-Prime Capital
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsExSight VenturesSolasta VenturesAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth Ventures+2 more
BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.
AI & Machine LearningDigital HealthHealthtechBranford, US
Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in
Board seatJohn Crumpler· per SEC Form D
Co-investorsConnecticut InnovationsExcelerate Health VenturesMartin Ventures
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Omer Inan(Co-founder, Chief Scientific Officer)inAndrew Carek(Co-founder, Chief Technical Officer)inAmit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan, PhD(Co-founder, Chief Scientific Officer)inAndrew Carek, PhD(Co-founder, Chief Technical Officer)in
Board seatLauren Pierce Flickinger· per SEC Form D
Co-investorsBayMed Venture PartnersBroadview VenturesCross-Border Impact VenturesLaerdal Million Lives FundOSF VenturesPortal Innovations+1 more
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Board seatClay ThorpChristy Shaffer· per SEC Form D
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalSolasta VenturesHatteras
Healthcare-enabling research organization that embeds clinical trials into everyday care using electronic health record data.
HealthtechAustin, US
Chad Moore(President)inJohn Potthoff(Chief Executive Officer)inJacylyn Bodmer(Chief Information Officer)Karen Flaherty(Vice President, Finance)inAmy Staedtler(Chief Legal Officer)inScott Treiber(Chief Operating Officer)in
Board seatJohn Crumpler· per SEC Form D
Co-investorsExcelerate Health VenturesNoro-Moseley PartnersNorwest Venture PartnersShumway Capital
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Jay Strum(Executive Officer)Norman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)
Board seatClay ThorpChristy Shaffer· per SEC Form D
Co-investorsLumira VenturesMountain Group CapitalRA CapitalSolasta Ventures
ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaSFairview, US
Mark Tuomenoksa(Co-Founder & Chief Technology Officer)inLauren Pierce Flickinger(Chief Executive Officer)inKate Rahimzadeh(Chief Operating Officer)inSandeep Goel(Executive Officer, Director, Promoter)
Board seatLauren Pierce Flickinger· per SEC Form D
Co-investorsHealth Catalyst Capital
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
BiotechHealthtechMedical DevicesMalvern, US
Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Chief Executive Officer)in
BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)
Board seatRobert IngramClay Thorp· per SEC Form D
Co-investorsMountain Group CapitalNew Enterprise Associates (NEA)Johnson & Johnson Innovation – JJDC
StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.
BiotechHealthtechDurham, US
Aravind Asokan(Director)inMavis Abjandje-McKenna(Director)Richard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)
Board seatClay ThorpMike Dial· per SEC Form D
Co-investorsPontifax Venture CapitalAbingworth
An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Ivana Magovcevic-Liebisch(Executive Officer, Director)Christopher Verni(Executive Officer)inMary Thistle(Director)Evan Thackaberry(Executive Officer)Suzanne Bruhn(Director)Gerhard Koenig(Director)
Board seatClay Thorp· per SEC Form D
Co-investorsAtlas VentureLightstone VenturesVida VenturesLongwood Fund
Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.
Digital HealthFemTechHealthtechSan Francisco, US
Leah Sparks(CEO & Founder)inKim Russell(Chief Financial Officer of Issuer)in
BoardDan Galles(Director of Issuer)inEzra Mehlman(Director of Issuer)Ralph Sabin(Director of Issuer)in
Board seatJohn Crumpler· per SEC Form D
Co-investorsAllumia VenturesEcho Health VenturesHealthtech Capital
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.
HardwareHealthtechMedical DevicesDurham, US
Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)in
BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in
Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersOSF VenturesWolfpack Investor NetworkArboretum Ventures+1 more
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)
BoardChristopher Perkins(Director)
Co-investorsAtlanta Technology AngelsCentral Texas Angel NetworkCheckmate Capital Group LLCIDEA NCJohnson Venture PartnersVentureSouth
AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.
HardwareHealthtechMedical Devices
Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)
Co-investorsArboretum VenturesBayMed Venture PartnersBroadview VenturesCatalyst Health Ventures
Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss.
BiotechDeep TechMedical DevicesAustin, US
Co-investorsLightstone VenturesSofinnova Ventures
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Iaso Ventures+8 more
HealthtechBurlington, US
Artur Adib(Founder/CEO)inTim Wall(Director)
Co-investorsBreyer CapitalDudley FundY Combinator1984 Ventures Management, LlcInflect HealthPromus Ventures
.png)
Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.
BiotechDigital HealthHealthtech
Barbara Lopez Kunz(Chief Executive Officer)inMichael Clay(Chief Operating Officer)inSharon Moore(Chief Medical Officer)inBrandon Pallott(Chief Commercial Officer)inMiron Lila(Chief Corporate Development Officer)inJohn Scott(Chief Information Officer)in
Co-investorsVivo Capital
Canopy Lawn Care provides science-based residential lawn care services using natural ingredients like coffee grounds, amino acids, probiotics, and sea kelp to promote soil health and reduce reliance on synthetic fertilizers and pesticides.
AgTechCleantechConsumer
Co-investorsElevate Innovation PartnersACME CapitalArrington CapitalBorderless CapitalFenbushi CapitalNyca Partners+2 more
Carpe manufactures clinical-grade antiperspirant and skincare products designed to reduce underarm sweat and odor for consumers.
ConsumerDirect to ConsumerHealthtechWellness & Fitness
Co-investorsLaunchCapital
Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials.
BiotechDigital HealthHealthtechMorrisville, US
Mark Ubert(Executive Officer)Jesse Watson(Director)Brian Carney(Director)Jeff L. Williams(Executive Officer, Director)Melissa Daniels(Director)Christopher K. Porter(Executive Officer)
Co-investorsCreathor VenturesOUP (Osage University Partners)
Clinverse was a Durham, NC-based fintech company that automated financial management for global clinical trials, including site payments, budgeting, and currency conversion via its ClinPay platform.
Durham, US
Joseph F. Trepanier(Executive Officer)M. Denis Connaghan(Executive Officer, Director)
BoardJohn Crumpler(Director)inAndy Strayer(Director)Kenneth B. Lee(Director)inNathaniel C. Brinn(Director)
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalAmgen VenturesJDRF T1D FundNorthpond VenturesTakeda Ventures+1 more
Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.
BiotechHealthtechDurham, US
Robin Hyde-DeRuyscher(Founder)inMoise Khayrallah(CEO)inMargaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)
Co-investorsRex Health VenturesWolfpack Investor NetworkVentureSouth
Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics.
BiotechDefense TechHealthtechMedical DevicesDurham, US
Bert Valada(President and CEO)inRichard Martin(Executive Officer)Susan Reyer(Executive Officer)Michael Galiger(Executive Officer)John Mowell(Director)Thomas Edwards(Director)
FilterEasy is an online retailer that sells home air filters directly to consumers, with a focus on delivery and subscription-based replacement.
ConsumerDirect to ConsumerE-commerceRaleigh, US
Thaddeus W. Tarkington(Executive Officer, Director)Kevin J. Barry(Executive Officer, Director)in
BoardSteve Dauphin(Director)David E. Gardner(Director)inLister Delgado(Director)inTom Lotrecchiano(Director)
Co-investorsCofounders CapitalElevate Innovation PartnersArsenalArsenal Growth EquityBonaventure CapitalIDEA Fund Partners+2 more
GoCheck Kids offers a smartphone-based MultiScreener that combines photoscreening, visual acuity, and pure tone audiometry to screen young children for vision and hearing problems.
Digital HealthHealthtechMedical Devices
David Huang(Founder)in
Co-investorsAloft VCFCA Venture PartnersMucker Capital
Gozio provides a mobile-first platform that helps health systems build patient-facing apps for navigating care, including indoor wayfinding and patient engagement.
Digital HealthHealthtechSaaSAtlanta, US
Joshua Titus(Executive Officer, Director)Dennis Keller(Executive Officer, Director)inKevin Lee(Executive Officer, Director)in
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.
BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB
Thomas Davison(Executive Officer, Director)inM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)
Co-investorsAlpha Wave GlobalAmzak HealthEarly Stage Partners, LPHealthQuest CapitalLumira VenturesMichigan Capital Network+3 more
Qoniq combines tailored AI analytics with expert guidance to help Medical Affairs and Scientific Affairs teams analyze large volumes of publications and datasets, surface patterns, and generate industry-standard, well-sourced scientific reports.
AI & Machine LearningBiotechHealthtechPalo Alto, US
Gregory Kostello(Executive Officer)Lana Feng(Executive Officer, Director)Susan Shiff(Executive Officer, Director)inWilliam Dai(Director)
BoardAndrew Schwab(Director)John Crumpler(Director)in
Co-investorsFusionSteelSky Ventures
Improved Nature produces plant-based protein products made from sustainably sourced non-GMO soy, targeting consumers seeking healthier and more environmentally responsible food options.
FoodTechHealthtechImpact & Social GoodGarner, US
Richard R. Hawkins(President/CEO)
BoardMoshe Meidan(Manager)Ken Campbell(Manager)Sarid M. Shefet(Manager)
Co-investorsWolfpack Investor NetworkConcentric
Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.
BiotechHealthtechDurham, US
Patrick Roberts(Executive Officer and member of the Board of Managers.)in
BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)
Co-investorsCape Fear BioCapitalEshelman Ventures, LLCHatteras
InnAVasc develops a vascular access graft for hemodialysis, featuring self-sealing pods and puncture-resistant backplates that guide dialysis needle placement to reduce needle-injury and bleeding complications.
BiotechHardwareHealthtechMedical DevicesDurham, US
Shawn Gage(Executive Officer)Jeffrey Lawson(Executive Officer, Director)Joseph Knight(Executive Officer, Director)Roberto Duane Manson(Executive Officer)
BoardDani Bolognesi(Director)
Co-investorsDuke Capital Partners
InvestorFlow provides an integrated front office platform for private markets firms, connecting capital formation, deployment, asset management, and investor services workflows in real time.
AI & Machine LearningEnterprise SoftwareFintechSaaS
Chris Ashrafi(Chief Revenue Officer)in
Co-investorsAmbina PartnersGrandBanks CapitalKPS Capital PartnersMerit Capital PartnersRelay InvestmentsSteelSky Ventures
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
BoardKirk Nielsen(Director)in
Co-investorsTreo Ventures, LlcVensana Capital
Jumo Health provides patient experience solutions for clinical trials, focusing on building patient readiness through education and behavioral systems rather than traditional recruitment.
Digital HealthHealthtech
Co-investorsExcelerate Health VenturesFalfurrias
Wilmington, US
Robert B Preville(Executive Officer, Director)Robert Kaiser(Executive Officer, Director)
BoardRandy Swartz(Director)
Co-investorsVentureSouth
Ladder Health provides digital health services focused on pediatric care and developmental screening, helping families navigate healthcare options for their children.
Digital HealthHealthtechBoston, US
Elizabeth Kidderin
Co-investors25MadisonGROOVE CAPITALJumpstart CapitalNina CapitalCREATE HEALTH VENTURES
Lysosomal Therapeutics Inc.
BiotechCambridge, US
Dimitri Krainc(Director)Robert Carpenter(Executive Officer, Director)Cornelis Been(Executive Officer, Director)
BoardSteven Hall(Director)Carole Nuechterlein(Director)inBernard Davitian(Director)
Co-investorsAtlas VentureLilly VenturesOmega FundsRoche Venture Fund
Melo Creative is a website design studio offering minimalist Showit website design and SEO strategy services for photographers and small business creatives.
Creator EconomyMarketing Tech
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardPaul Meister(Director)Sonja Hoel Perkins(Director)in
Co-investorsiSelect FundMindshift CapitalNovalis LifeSciencesPortfoliaSozo VenturesThe Perkins Fund
CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis.
AI & Machine LearningBiotechHealthtechMedical DevicesCambridge, US
Daniel Getts, Ph.D.(Chief Executive Officer, Cofounder, Board Director)
Co-investorsARCH Venture Partners8VCNewpath Partners
HealthStream's Nursegrid Unlimited CE is a subscription service offering nurses unlimited access to continuing education courses that meet state-specific regulatory requirements for nursing practice compliance.
ConsumerDigital HealthEdTechFuture of WorkHealthtechHR TechSaaS
Co-investorsExcelerate Health VenturesPortland Seed FundToba CapitalArboretum Ventures
NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension.
BiotechHealthtechLongevityNashville, US
Michael Zemel(Executive Officer, Director)Barbara Cannon(Executive Officer)Joseph C. Cook, Jr.(Executive Officer, Director)
BoardEric Satz(Director)Vaughn Bryson(Director)Brian Laden(Director)
Co-investorsMountain Group Capital
Orbital RX provides a software platform for hospital pharmacy supply chain management that integrates inventory tracking, procurement workflows, and real-time team collaboration to coordinate shortage response across healthcare networks.
AI & Machine LearningEnterprise SoftwareHealthtechSaaS
Nate Peaty(Founder)in
Co-investorsAlerion VenturesExcelerate Health VenturesThe Launch PlaceGood Life Sciences Generations
Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Sevgi Gurkan, MD(Founder, Chief Executive Officer, and Member of the Board of Directors)in
BoardChristy Shaffer(Director)Chau Khuong(Director)inSevgi Gurkan(Executive Officer, Director, Promoter)in
Co-investorsOrbiMedAccess BiotechnologyCatalio Capital Management, LPLAVLilly Asia VenturesHatteras
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.
BiotechDeep TechHealthtechMedical Devices
Mark Wagner(Founder, Investor, & Director in Pharaoh)inDr. Nandan Lad(Chief Medical Officer & Co-Founder)Rich Nazarian(Founder, Investor, & Director in Pharaoh)inAmaza Reitmeier(Chief Executive Officer, Director)in
Co-investorsArboretum VenturesIAG Capital PartnersLaerdal Million Lives Fund
Pryon provides a memory layer platform that helps enterprises move AI projects into production by ingesting, governing, and securing content across multiple formats and sources.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise Software
Co-investors7BC Venture CapitalAperture Venture CapitalDuke Capital PartnersGood Growth CapitalGreycroftIronGate Capital Advisors+4 more
QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria.
BiotechHealthtechSan Diego, US
Michael N. Dudley(Executive Officer, Director)inTerry Gould(Director)Daniel Burgess(Director)
BoardCarol Gallagher(Director)inDouglas Reed(Director)inKevin Li(Director)in
Co-investorsLYZZ CapitalNew Enterprise Associates (NEA)Adams Street Partners
RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsBroadview VenturesEpidarex Capital
restor3d designs and manufactures patient-specific 3D-printed orthopaedic implants for musculoskeletal reconstruction, using osseointegrative biomaterials, AI-driven design, and digital health tools.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDurham, US
Cambre Kelly(Executive Officer)inKenneth Gall(Executive Officer, Director)Kurt Jacobus(Executive Officer, Director)inAndrew Miller(Executive Officer)Michael Fillion(Executive Officer)Greg Anglum(Executive Officer)in
Co-investorsDuke Capital Partners
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsAbbVie+2 more
HealthtechCambridge, US
Adam Rosenberg(Executive Officer, Director)in
BoardBruce Booth(Director)inKees Been(Director)Samantha Singer(Director)
Co-investorsGV (Google Ventures)Third Point VenturesAtlas VentureJJDCRemeditex Ventures
Roobrik provides science-based online surveys, financial-readiness assessments, and chat tools that help prospective senior living residents and their families evaluate their options while converting more website visitors into qualified leads for senior living providers.
Digital HealthHealthtechMarketing TechSaaSSales TechGreensboro, US
Nate O'Keefe(Founder)inJudith Conaway(Executive Officer)David Levin(Director)inMaureen O'Connor(Director)William Clark(Director)
Co-investorsIDEA NCJurassic CapitalThe Launch PlaceThird Act Ventures
Rx Redefined provides a platform and management services for DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) ordering, handling revenue cycle processes, compliance checks, and audit processing for physicians.
BiotechDigital HealthHealthtechMedical DevicesSaaSArroyo Grande, US
Brandon Boots(Founder & CEO)inErik Smith(Executive Officer, Director)
BoardIan Chiang(Director)inRoger Chen(Director)in
Co-investorsCrosscut VenturesFlare Capital PartnersSilverton PartnersNew Enterprise Associates (NEA)Saturn FiveTusk Venture Partners
SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments.
Digital HealthHealthtechMobility & Transportation
Robbins Schrader(Chief Executive Officer, Co-Founder)Ben Salter(Chief Product Officer, Co-Founder)inWhit Schrader(VP of Ops Transformation, Co-Founder)in
Co-investorsAmplify.LABonfire VenturesFCA Venture PartnersFresenius Medical Care VenturesHDS CapitalLayout Ventures+5 more
Sailthru is a cross-channel marketing platform that lets brands run personalized email, SMS, mobile push, in-app, and web campaigns using AI-driven unified customer profiles.
AI & Machine LearningMarketing TechSaaSNew York, US
Neil Capel(Co-founder, Chief Executive Officer; later Chairman)Ian White(Co-founder and Chief Technology Officer)inChris Chapman(Co-founder / engineering leader)Amy Shapero(Chief Financial Officer)Neil Lustig(Chief Executive Officer)in
BoardStacey Bishop(Board Director (Scale Venture Partners))in
Co-investorsBowery CapitalRunway Venture PartnersThrive CapitalBenchmarkRRE VenturesScale Venture Partners
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCIter InvestmentsMission BiocapitalRoute 66 VenturesService Provider CapitalSante Health Ventures+1 more
SportsEngine provides technology for youth sports organizations to manage team scheduling, registration, payments, communication, live streaming, and tournaments.
ConsumerSaaSSports TechRaleigh, US
Paul Dorney(Executive Officer)Brendan Szulik(Executive Officer, Director, Promoter)John Lambert(Executive Officer, Director, Promoter)Daniel Caldwell(Executive Officer, Director, Promoter)
BoardMatthew Szulik(Director)
Co-investorsIDEA Fund Partners
BiotechResearch Triangle Park, US
Andrew Jordan(Executive Officer, Director)John Taylor(Executive Officer, Director, Promoter)Robert Tarran(Director)
BoardDonald Rose(Director)
Co-investors5AM VenturesCanaan Partners
Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.
Medical Devices
Co-investorsCincyTechEmergent Medical Partners, LLPJobsOhio VenturesRC CapitalRiverVest Venture PartnersUS Venture Partners
Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief.
BiotechDigital HealthMedical DevicesAlpharetta, US
Shyamy Sastry(Executive Officer, Director)
BoardDoug Reed(Director)Robert Crutchfield(Executive Officer, Director)Anita Watkins(Director)inKurt Jacobus(Director)in
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)inMarcel Frenkel(Executive Officer, Director)Damien Petty(Director)inJia Wei Xu(Director)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesDuke Capital PartnersAbbVieAlexandria+4 more
ThreatSwitch offers a compliance management platform that automates workflows such as travel requests, new hire onboarding, and security training, and centralizes task management, data tracking, and reporting in a shared workspace.
Enterprise SoftwareGovTechSaaSCharlotte, US
John M Dillard(Executive Officer, Director)in
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Executive Officer)inDerek Jantz(Executive Officer)inCharles Gersbach(Director)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Executive Officer, Director)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalYosemite
Durham, US
Jesko von Windheim(Executive Officer, Director)Richard N. Scott(Executive Officer)Timothy S. Tracey(Executive Officer, Director)Jill Marcotte(Director)Matt Bittner(Director)
Co-investorsDuke Capital Partners
Viamet provides a resource for people to organize questions and conduct research about medical travel, provider verification, care coordination, and health-related travel planning.
Digital HealthHealthtechTravel & HospitalityWellness & Fitness
Co-investorsAstellas Venture Management LLCLilly VenturesNovartis Venture FundWoodford Investment Management
AgTechDurham, US
Tracy Jackson(Executive Officer)John Riley(Director)Joel Marcus(Director)John Dombrosky(Executive Officer, Director)
Co-investorsS2G Investments
Vital Plan sells herbal supplements and nutrient formulas aimed at supporting cellular health and overall wellness, including its RESTORE180 program for people managing chronic health challenges.
ConsumerDirect to ConsumerWellness & FitnessRaleigh, US
Braden Rawls(Executive Officer, Director)inDr. Bill Rawls(Co-founder)
BoardWalter Clarke(Director)
Co-investorsThe Launch Place
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Dance Biopharm Holdingsi2i SystemsIMMvention TherapeutixKivoMedfusionMedikidzOrig3NPIPr TherapeuticsViamet Pharmaceuticals Holdings LlcWFS Home Care Enterprises401 MedicalAltisArtus Labs IncAthome HarmonyAtsena TherapeuticsAxonisBackrsBivarus IncBoomerangBoston Immune Technologies & TherapeuticsBoston Immune Technologies And Therapeutics BittCarallelCGI PharmaceuticalsClearside Bio IncCode BioCoferonConfigohealthCREATE MedicinesCuroverseDropworksEmbrella Cardiovascular IncEndogenexEvoAppFirstGoCheckGraybug Vision, Inc.ImmventionIncylix BioIris HealthcareLysosomalMMvention Therapeutix, Inc.NeuroTronikPanaceuticsPanaceutics NutritionPathfinder TherapeuticsQvellaRapidPulseSeaportdxSensoriumSpineAlign MedicalSpolia TherapeuticsSyntheon 2.0TethisTetraLogic PharmaceuticalsTheclimateserviceVeraloxVeralox TherapeuticsViamet PharmaceuticalsVirchoVircho HealthWesper
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 19
5 IPOs · 14 acquisitions · showing 14AlkermesNASDAQ: ALKSAN2 TherapeuticsNASDAQ: ANTXCVRxNASDAQ: CVRXKymera TherapeuticsNASDAQ: KYMRShattuck LabsNASDAQ: STTKMedfusionacq. by NextGen HealthcareViamet Pharmaceuticals Holdings Llcacq. by Aralez PharmaceuticalsArtus Labs Incacq. by PerkinelmerBivarus Incacq. by Press Ganey AssociatesClinverse Incacq. by BioclinicaCuroverseacq. by Veritas GeneticsEmbrella Cardiovascular Incacq. by Edwards LifesciencesIris Healthcareacq. by AledadeVeralox Therapeuticsacq. by Cadrenal Therapeutics
Portfolio news
latest coverage across their companies
Canopy · aol.com · Sep 5, 2026
Altis Biosystems · tweenertimes.com · Aug 27, 2026
410 Medical · intelligence360.news · Aug 25, 2026
AN2 Therapeutics · ng.investing.com · Aug 19, 2026
Shattuck Labs · stocktitan.net · Aug 14, 2026
SafeRide Health · trysignalbase.com · Jul 28, 2026
Pharaoh Neuro · arboretumvc.com · Jul 27, 2026
Ladder Health · healthcareittoday.com · Jul 17, 2026
Fund performance · per public LP disclosures · 2
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Hatteras Venture Partners VLPs: San Diego City Employees' Retirement System | 2015 | — | 35.3% | 2.08x | 1.35x |
| Hatteras Venture Partners III, L.P.LPs: North Carolina Retirement Systems | 2007 | — | 0.3% | — | — |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2023
Disclosed stake · filed Jan 2023
Disclosed stake · filed Dec 2019
Disclosed stake · filed Jul 2019
Disclosed stake · filed Jul 2019
Disclosed stake · filed Nov 2018
Disclosed stake · filed Nov 2018
Disclosed stake · filed Mar 2018
Disclosed stake · filed Apr 2017
Disclosed stake · filed Feb 2017
Disclosed stake · filed Jun 2016
5 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Hatteras Venture Partners made?
- Hatteras Venture Partners has 145 tracked investments, 19 of which have exited, including 13 dated in the last 24 months.
- What stage does Hatteras Venture Partners invest at?
- Hatteras Venture Partners invests at the Seed, Series A, Series B, Series C stages.
- What is Hatteras Venture Partners's typical check size?
- Hatteras Venture Partners typically writes checks of $500K – $4M.
- What sectors does Hatteras Venture Partners focus on?
- Hatteras Venture Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Hatteras Venture Partners located?
- Hatteras Venture Partners is headquartered in Research Triangle, US.
- Does Hatteras Venture Partners lead rounds?
- Hatteras Venture Partners typically participates in rounds rather than leading them.
- Who does Hatteras Venture Partners co-invest with?
- Hatteras Venture Partners most often shares deals with Arboretum Ventures, Excelerate Health Ventures, New Enterprise Associates (NEA), among 107 tracked co-investors.
Images
Co-investors · 23
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Vensana Capital is a venture capital and growth equity investment firm focused on partnering with entrepreneurs building breakthrough medical technology innovations to transform healthcare.
AbbVie Ventures is the corporate venture capital arm of biopharmaceutical company AbbVie, investing in early-stage companies in oncology, immunology, and neurodegenerative diseases that complement the parent company's research and development pipeline.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
▶11 more co-investors
Mayfield FundFusion5AM VenturesMorpheus VenturesOmega FundsRoche Venture FundToba CapitalCatalio Capital Management, LPJDRF T1D FundRebel FundPJC
Firms observed investing alongside Hatteras Venture Partners, from public investor directories. Shared companies are the overlap with Hatteras Venture Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.